These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11459995)

  • 1. Phase I trial of i.v. administered tirapazamine plus cyclophosphamide.
    Hoff PM; Saad ED; Ravandi-Kashani F; Czerny E; Pazdur R
    Anticancer Drugs; 2001 Jul; 12(6):499-503. PubMed ID: 11459995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study.
    Aquino VM; Weitman SD; Winick NJ; Blaney S; Furman WL; Kepner JL; Bonate P; Krailo M; Qu W; Bernstein M
    J Clin Oncol; 2004 Apr; 22(8):1413-9. PubMed ID: 15084615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors.
    Shulman LN; Buswell L; Riese N; Doherty N; Loeffler JS; von Roemeling RW; Coleman CN
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):349-53. PubMed ID: 10760430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma.
    Bedikian AY; Legha SS; Eton O; Buzaid AC; Papadopoulos N; Plager C; McIntyre S; Viallet J
    Anticancer Drugs; 1999 Sep; 10(8):735-9. PubMed ID: 10573206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: a california cancer consortium phase I and molecular correlative study.
    Lara PN; Frankel P; Mack PC; Gumerlock PH; Galvin I; Martel CL; Longmate J; Doroshow JH; Lenz HJ; Lau DH; Gandara DR
    Clin Cancer Res; 2003 Oct; 9(12):4356-62. PubMed ID: 14555506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of tirapazamine in combination with cisplatin in a single dose every 3 weeks in patients with solid tumors.
    Johnson CA; Kilpatrick D; von Roemeling R; Langer C; Graham MA; Greenslade D; Kennedy G; Keenan E; O'Dwyer PJ
    J Clin Oncol; 1997 Feb; 15(2):773-80. PubMed ID: 9053504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation.
    Doherty N; Hancock SL; Kaye S; Coleman CN; Shulman L; Marquez C; Mariscal C; Rampling R; Senan S; Roemeling RV
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):379-82. PubMed ID: 8195037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 1 study of tirapazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer.
    Rischin D; Narayan K; Oza AM; Mileshkin L; Bernshaw D; Choi J; Hicks R; McClure B; Fyles A
    Int J Gynecol Cancer; 2010 Jul; 20(5):827-33. PubMed ID: 20606530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.
    von Pawel J; von Roemeling R; Gatzemeier U; Boyer M; Elisson LO; Clark P; Talbot D; Rey A; Butler TW; Hirsh V; Olver I; Bergman B; Ayoub J; Richardson G; Dunlop D; Arcenas A; Vescio R; Viallet J; Treat J
    J Clin Oncol; 2000 Mar; 18(6):1351-9. PubMed ID: 10715308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tirapazamine-cisplatin: the synergy.
    Gatzemeier U; Rodriguez G; Treat J; Miller V; von Roemeling R; Viallet J; Rey A
    Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):15-7. PubMed ID: 9647615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study.
    Le QT; McCoy J; Williamson S; Ryu J; Gaspar LE; Edelman MJ; Dakhil SR; Sides SD; Crowley JJ; Gandara DR;
    Clin Cancer Res; 2004 Aug; 10(16):5418-24. PubMed ID: 15328179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
    Valero V
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.
    Williamson SK; Crowley JJ; Lara PN; McCoy J; Lau DH; Tucker RW; Mills GM; Gandara DR;
    J Clin Oncol; 2005 Dec; 23(36):9097-104. PubMed ID: 16361616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
    Jounaidi Y; Waxman DJ
    Cancer Res; 2000 Jul; 60(14):3761-9. PubMed ID: 10919648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial.
    Graham MA; Senan S; Robin H; Eckhardt N; Lendrem D; Hincks J; Greenslade D; Rampling R; Kaye SB; von Roemeling R; Workman P
    Cancer Chemother Pharmacol; 1997; 40(1):1-10. PubMed ID: 9137522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of tirapazamine and cisplatin in patients with recurrent cervical cancer.
    Aghajanian C; Brown C; O'flaherty C; Fleischauer A; Curtin J; Roemeling R; Spriggs DR
    Gynecol Oncol; 1997 Nov; 67(2):127-30. PubMed ID: 9367694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.
    Bonnefoi H; Biganzoli L; Cufer T; Mauriac L; Hamilton A; Schaefer P; Piccart M
    Breast Cancer Res Treat; 2001 Nov; 70(1):55-63. PubMed ID: 11768362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer.
    Craighead PS; Pearcey R; Stuart G
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):791-5. PubMed ID: 11020576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell support.
    Morgan RJ; Doroshow JH; Venkataraman K; Chang K; Raschko J; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Margolin K; Forman S; Akman S; Coluzzi P; Ahn C; Weiss L; Gadgil U; Harrison J
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2337-45. PubMed ID: 9815632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.
    Senan S; Rampling R; Graham MA; Wilson P; Robin H; Eckardt N; Lawson N; McDonald A; von Roemeling R; Workman P; Kaye SB
    Clin Cancer Res; 1997 Jan; 3(1):31-8. PubMed ID: 9815534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.